The L-carnitine market was valued at USD 220.79 million in 2024, with USD 230.68 million estimated for 2025 and USD 348.17 million projected by 2034, at a CAGR of 4.70% across the 2025–2034 forecast period. The report segments the market by process, product, application, and region. Companies such as Cayman Chemical, Ceva Animal Health Pty Ltd, Huanggang Huayang Pharmaceutical Co. Ltd.,...